AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glydin M 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Divine Savior Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glydin M 80mg/500mg Tablet SR

DiaGlycin-80/500 SR tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. DiaGlycin-80/500 SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical supervision can elevate blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods or juice) is essential for hypoglycemia management. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. DiaGlycin-80/500 SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glydin M 80mg/500mg Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glydin M 80mg/500mg Tablet SR

Non-insulin-dependent diabetes

Major Benefits of Glydin M 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glydin M 80mg/500mg Extended-Release tablets with a meal.

Common Side effects of Glydin M 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glydin M 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glydin M 80mg/500mg Sustained-Release tablets should be taken with meals.

How Glydin M 80mg/500mg Tablet SR works:

Glydin M 80mg/500mg sustained-release tablets contain gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glydin M 80mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glydin M 80mg/500mg sustained-release tablets is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glydin M 80mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glydin M 80mg/500mg SR tablets, potentially requiring dosage modification. Physician consultation is recommended. Glydin M 80mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glydin M 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Individuals with severe liver disease should avoid this medication; those with mild to moderate liver disease should begin with a reduced dose. Medical advice is recommended.

What if you forget to take Glydin M 80mg/500mg Tablet SR :

Should you forget a Glydin M 80mg/500mg SR Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glydin M 80mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glydin M 80mg/500mg Tablet SR

Glydin M 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glydin M 80mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glydin M 80mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glydin M 80mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who avoid excessive alcohol consumption. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glydin M 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged Glydin M 80mg/500mg Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glydin M 80mg/500mg SR tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Glydin M 80mg/500mg Tablet SR is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glydin M 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glydin M 80mg/500mg Tablet SR commonly causes side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, may also occur. Prolonged use can result in vitamin B12 deficiency.
Glydin M 80mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glydin M 80mg/500mg Tablet SR can cause lactic acidosis, a serious, potentially fatal condition (also known as MALA—Metformin-associated lactic acidosis) resulting from excess lactic acid in the blood. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glydin M and seek immediate medical attention.
Prolonged use of Glydin M 80mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glydin M 80mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Glydin M 80mg/500mg SR tablets is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glydin M 80mg/500mg Table...
54
MRP 66
18% off